Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gerard

Showing results (231-240 of 246) with videos related to

Pageof 25
Sort By:
Stroke (Hoboken, N.J.)|January 23, 2026
Association of Fibrinolysis With Acute Ischemic Stroke Outcome in Patients Undergoing Thrombectomy: Modification by Additional Administration of tPA?Aarazo Barakzie, Fabiano Cavalcante, Samantha J Donkel, et al.
Nature Protocols|September 11, 2023
A workflow for the development of template-assisted membrane crystallization downstream processing for monoclonal antibody purificationNazer Rajoub, Charline J J Gerard, Elvira Pantuso, et al.
Blood Advances|February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopeniaDavid J Kuter, Jiri Mayer, Merlin Efraim, et al.
American Journal of Hematology|January 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B StudyNichola Cooper, A J Gerard Jansen, Robert Bird, et al.
Circulation|January 20, 2018
Complement Receptor C5aR1 Plays an Evolutionarily Conserved Role in Successful Cardiac RegenerationNiranjana Natarajan, Yamen Abbas, Donald M Bryant, et al.
Blood Advances|July 2, 2020
Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicityA J Gerard Jansen, Thom Spaan, Hui Zhi Low, et al.
British Journal of Haematology|September 27, 2022
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patientsMaurice Swinkels, Ferdows Atiq, Petra E Bürgisser, et al.
Blood Advances|December 23, 2021
COVID-19 vaccination in patients with immune thrombocytopeniaChantal Visser, Maurice Swinkels, Erik D van Werkhoven, et al.
Cancer|May 24, 2023
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocolBiniam Kidane, Ian J Gerard, Jonathan Spicer, et al.
The New England Journal of Medicine|April 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune ThrombocytopeniaDavid J Kuter, Merlin Efraim, Jiri Mayer, et al.
Pageof 25

Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Stroke (Hoboken, N.J.)|January 23, 2026
Association of Fibrinolysis With Acute Ischemic Stroke Outcome in Patients Undergoing Thrombectomy: Modification by Additional Administration of tPA?Aarazo Barakzie, Fabiano Cavalcante, Samantha J Donkel, et al.
Nature Protocols|September 11, 2023
A workflow for the development of template-assisted membrane crystallization downstream processing for monoclonal antibody purificationNazer Rajoub, Charline J J Gerard, Elvira Pantuso, et al.
Blood Advances|February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopeniaDavid J Kuter, Jiri Mayer, Merlin Efraim, et al.
American Journal of Hematology|January 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B StudyNichola Cooper, A J Gerard Jansen, Robert Bird, et al.
Circulation|January 20, 2018
Complement Receptor C5aR1 Plays an Evolutionarily Conserved Role in Successful Cardiac RegenerationNiranjana Natarajan, Yamen Abbas, Donald M Bryant, et al.
Blood Advances|July 2, 2020
Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicityA J Gerard Jansen, Thom Spaan, Hui Zhi Low, et al.
British Journal of Haematology|September 27, 2022
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patientsMaurice Swinkels, Ferdows Atiq, Petra E Bürgisser, et al.
Blood Advances|December 23, 2021
COVID-19 vaccination in patients with immune thrombocytopeniaChantal Visser, Maurice Swinkels, Erik D van Werkhoven, et al.
Cancer|May 24, 2023
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocolBiniam Kidane, Ian J Gerard, Jonathan Spicer, et al.
The New England Journal of Medicine|April 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune ThrombocytopeniaDavid J Kuter, Merlin Efraim, Jiri Mayer, et al.
Pageof 25